
Sirolimus Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 1 mg, 2 mg, 3 mg, 5 mg tablets
Reference Brands: Rapamune(US)
Category: Immune Disorder
Sirolimus tablet is available in Tablet and strengths such as 1 mg, 2 mg, 3 mg, 5 mg tablets. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Sirolimus tablet is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Sirolimus tablet can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Sirolimus tablets, marketed as Rapamune, are approved in the US by the FDA and in the EU via EMA for preventing organ rejection and treating certain autoimmune conditions. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety, manufacturing data, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and manufacturing information, while the EMA ensures compliance with regional standards. For guidance on dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Ensuring adherence to regional regulations is essential for the safe, effective, and timely approval of sirolimus tablets worldwide, supporting optimal patient outcomes in transplantation and autoimmune therapy.
Frequently Asked Questions
Related Products
Belimumab Prefilled Syringe
Strength: 200 mg/ten 1 mL for SQ; 10 mg/mL for IV
Form: Subcutaneous (SC) and intravenous (IV) Prefilled syringe
Reference Brands: Benlysta(US & EU)
View DetailsAnakinra Injection
Strength: 100 mg/mL
Form: Injection(SQ)
Reference Brands: Kinerso, Kineret(US)
View DetailsIvig (Intravenous Immunoglobulin) Solution
Strength: 5% or 10%
Form: Intravenous infusion
Reference Brands: Gammagard (Gamunex-C, Flebogamma),Privigen, Octagam, Gamunex-C(US)
View DetailsUstekinumab Injection
Strength: SQ:: 45 mg, 90 mg; IV: 130 mg/vial
Form: SQ and IV injection
Reference Brands: Stelara(US)
View DetailsQuick Response Guaranteed | Verified Suppliers